YOLFTbeta
Ypsomed Holding AG

Ypsomed Holding AG

YPSN · SW · Healthcare / Medical Instruments & Supplies

430.40CHF-6.80 (-1.56%)

Price History

Full chart

Market Stats

Previous Close437.20
Open436.20
Day Range428.80 – 437.60
52-Week Range257.32 – 418.00
Volume16.80K
Market Cap4.82B
P/E (TTM)22.49
Forward P/E25.38
EPS16.30
Dividend Yield1.23%
Beta0.81
50-Day Avg384.66
200-Day Avg334.16

About

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication in Switzerland, Europe, North America, and internationally. The company offers various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other related services. It offers contract manufacturing of infusion sets and reservoirs. The company markets its products to hospitals, doctors, pharmacies and patients via subsidiaries and distributors. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Simon Michel
  • Employees2.02K
  • HeadquartersBrunnmattstrasse 6, Burgdorf, Switzerland, 3401, Switzerland
  • Websitehttps://www.ypsomed.com

Leadership

  • Mr. Simon MichelCEO, Member of Executive Board & Member of the Board · b. 1977
  • Mr. Samuel KunzliChief Financial Officer & Member of Executive Board · b. 1984
  • Ms. Ulrike BauerChief Business Officer & Member of Executive Board · b. 1969
  • Mr. Frank MengisCOO, Deputy CEO Member of Executive Board · b. 1964
  • Mr. Michael ZauggChief Corporate Officer & Member of Executive Board · b. 1972
  • Dr. Nicolas MeyerChief Legal Officer & Secretary and Member of Executive Board · b. 1971
  • Sam GhezelbashHead of Investor Relations & M&A

Financials

Income Statement

Currency: CHF2002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue100.61M137.19M185.37M241.82M310.59M277.45M287.47M272.58M254.01M242.46M248.59M244.56M276.26M306.63M336.92M389.56M466.12M453.76M394.26M403.66M464.84M497.46M548.46M748.87M730.98M
Growth (%)-+36.35%+35.12%+30.46%+28.44%-10.67%+3.61%-5.18%-6.81%-4.55%+2.53%-1.62%+12.96%+11.00%+9.88%+15.62%+19.65%-2.65%-13.11%+2.38%+15.16%+7.02%+10.25%+36.54%-2.39%
Cost of Revenue74.95M94.92M113.64M144.94M191.38M213.21M197.27M188.58M187.57M175.74M192.22M187.49M205.73M220.78M233.74M264.08M326.29M297.35M303.29M308.83M351.02M356.87M359.40M456.80M416.38M
Gross Profit25.66M42.27M71.72M96.89M119.21M64.24M90.20M84.00M66.45M66.72M56.37M57.08M70.53M85.85M103.19M125.48M139.83M156.41M90.97M94.83M113.82M140.59M189.05M292.07M314.61M
Gross Margin25.50%30.81%38.69%40.07%38.38%23.15%31.38%30.82%26.16%27.52%22.68%23.34%25.53%28.00%30.63%32.21%30.00%34.47%23.07%23.49%24.49%28.26%34.47%39.00%43.04%
Operating Expense18.97M28.07M54.49M75.63M56.87M61.90M59.22M53.58M53.00M58.11M51.23M52.23M54.98M58.91M58.93M70.20M78.96M83.25M89.16M85.56M85.24M80.00M102.83M179.22M68.53M
Operating Income6.69M14.20M17.23M21.26M62.34M2.34M30.98M30.43M13.45M8.61M5.14M4.85M15.54M26.95M44.25M55.28M60.87M73.16M1.82M9.27M28.58M60.59M86.22M112.85M246.07M
Operating Margin6.65%10.35%9.30%8.79%20.07%0.84%10.78%11.16%5.29%3.55%2.07%1.98%5.63%8.79%13.13%14.19%13.06%16.12%0.46%2.30%6.15%12.18%15.72%15.07%33.66%
EBITDA18.66M27.65M47.31M43.07M92.19M27.40M55.20M53.46M39.91M33.91M36.98M29.32M35.32M47.41M64.64M86.56M97.08M115.59M61.63M65.19M96.66M137.51M161.56M190.90M326.36M
EBITDA Margin18.55%20.15%25.52%17.81%29.68%9.88%19.20%19.61%15.71%13.98%14.87%11.99%12.79%15.46%19.19%22.22%20.83%25.47%15.63%16.15%20.79%27.64%29.46%25.49%44.65%
Net Income5.78M12.06M11.59M39.20M55.65M2.74M26.58M26.17M9.43M5.21M8.50M1.65M13.61M19.39M35.81M46.25M52.06M60.14M11.73M5.81M23.11M51.27M78.37M87.50M221.93M
Net Income Margin5.74%8.79%6.25%16.21%17.92%0.99%9.25%9.60%3.71%2.15%3.42%0.67%4.93%6.33%10.63%11.87%11.17%13.25%2.98%1.44%4.97%10.31%14.29%11.68%30.36%
R&D795.00K4.56M6.40M40.58M17.21M21.91M43.23M10.46M7.32M9.25M-26.98M27.71M33.46M32.26M38.66M40.55M56.84M42.00M16.79M21.95M28.95M30.48M33.55M40.02M
R&D as % of Total Revenue0.79%3.32%3.45%16.78%5.54%7.90%15.04%3.84%2.88%3.81%-11.03%10.03%10.91%9.57%9.93%8.70%12.53%10.65%4.16%4.72%5.82%5.56%4.48%5.48%
Interest Expense26.00K47.00K01.60M1.07M1.23M4.05M6.87M2.66M2.60M785.00K874.00K1.04M845.00K632.80K477.55K656.00K827.39K980.00K2.02M2.27M2.31M5.04M6.64M3.18M
Interest Expense % of Total Revenue0.03%0.03%0.00%0.66%0.34%0.44%1.41%2.52%1.05%1.07%0.32%0.36%0.38%0.28%0.19%0.12%0.14%0.18%0.25%0.50%0.49%0.46%0.92%0.89%0.44%

Balance Sheet

Currency: CHF2002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets117.12M142.96M500.78M658.48M665.70M622.79M638.23M632.22M662.01M674.63M327.27M341.79M354.53M361.21M388.87M421.80M500.24M587.75M678.24M717.68M756.91M861.88M1.10B1.33B1.35B
Total Liabilities21.54M31.28M488.94M301.31M261.69M232.76M220.65M195.19M124.27M136.58M109.27M124.42M126.37M120.57M121.03M120.00M158.70M208.94M292.89M322.30M364.37M299.55M483.66M650.66M598.46M
Total Equity95.58M111.68M11.84M357.17M404.01M390.03M417.58M437.03M537.74M538.06M218.00M217.37M228.16M240.64M267.84M301.80M341.54M378.80M375.17M395.38M392.54M562.33M617.73M679.68M748.13M
Cash1.93M3.89M12.62M55.98M65.67M40.72M38.29M8.99M8.06M5.02M9.73M9.61M16.16M16.24M25.51M38.88M32.11M12.08M12.17M18.15M15.86M24.48M74.02M36.49M28.56M
Total Debt----200.00M180.00M----14.50M20.00M20.00M15.00M49.00M37.06M59.00M122.00M193.00M215.00M267.00M157.00M256.00M267.00M260.77M
Net Debt-1.93M-3.89M-12.62M-55.98M134.33M139.28M-38.29M-8.99M-8.06M-5.02M4.76M10.39M3.84M-1.24M23.49M-1.88M26.89M109.92M180.83M196.85M251.14M132.52M181.98M230.50M232.21M

Cash Flow

Currency: CHF2002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow6.50M20.40M26.54M94.78M46.37M30.96M70.16M48.40M22.48M29.50M31.05M15.17M41.21M41.38M76.69M75.06M53.27M59.86M49.09M85.83M85.71M129.53M163.22M148.20M306.76M
Investing Cash Flow-18.47M-22.48M-38.75K66.37M-9.43M-19.10M52.31M49.59M-43.74M-27.46M-19.78M-26.29M-30.06M-26.23M-35.98M-38.05M-65.82M-128.39M-115.83M-106.91M-125.70M-122.02M-195.07M-267.27M-27.49M
Financing Cash Flow12.86M4.04M17.38M14.96M-27.28M-36.90M20.13M28.04M20.49M-4.91M-6.42M10.96M-4.52M-14.17M-31.66M-23.23M4.59M49.09M68.66M26.67M38.13M1.26M81.07M82.25M-286.45M
Capital Expenditure18.74M22.92M38.01M72.47M30.55M23.40M53.35M046.38M26.22M15.93M26.41M18.53M17.21M25.15M27.48M51.03M106.80M118.73M126.58M127.43M169.17M195.31M277.15M323.10M
Free Cash Flow-12.24M-2.52M-11.47M22.30M15.82M7.56M16.81M48.40M-23.90M3.28M15.13M-11.24M22.68M24.17M51.53M47.58M2.24M-46.94M-69.64M-40.75M-41.72M-39.64M-32.09M-128.95M-16.34M
Dividends Paid----------2.53M2.52M2.52M3.78M7.58M12.61M16.41M17.64M6.93M2.52M14.67M8.19M17.75M27.30M30.02M
FCF to OCF-188.50%-12.36%-43.24%23.53%34.12%24.42%23.96%100.00%-106.32%11.12%48.72%-74.12%55.03%58.41%67.20%63.39%4.21%-78.42%-141.87%-47.48%-48.68%-30.60%-19.66%-87.01%-5.33%
Dividend Paid to FCF----------16.73%-22.44%11.13%15.66%14.70%26.51%732.08%-37.59%-9.95%-6.19%-35.15%-20.66%-55.30%-21.17%-183.68%

Earnings

Report DateMay 20, 2016Nov 24, 2016Jun 14, 2017Nov 10, 2017May 25, 2018Nov 6, 2018May 23, 2019Nov 6, 2019May 27, 2020Nov 3, 2020May 27, 2021Nov 4, 2021May 25, 2022Nov 16, 2022May 24, 2023Nov 13, 2024May 21, 2025Nov 12, 2025Nov 11, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.00--0.000.00--
EPS Actual1.631.781.891.862.284.450.320.600.310.52-0.060.561.261.172.632.394.0210.19-
Surprise-------------------
Timing-----------Pre-marketPre-marketAfter-hoursAfter-hours--After-hoursPre-market

Key Statistics & Ratios

Market Cap4.82B
Enterprise Value4.94B
Trailing P/E22.49
Forward P/E25.38
PEG Ratio3.21
Price / Sales6.59
Price / Book6.29
EPS16.30
Book Value59.15
Revenue (TTM)730.98M
Gross Profit (TTM)314.61M
EBITDA325.79M
Profit Margin30.36%
Operating Margin26.45%
Return on Equity31.09%
Return on Assets12.36%
Shares Outstanding13.15M
Shares Float3.51M
Beta0.81
Dividend Yield1.23%
Dividend Rate4.40
Payout Ratio43.18%

Dividends

20261×
4.40Jul 3, 2026
20251×
2.20Jul 4, 2025
20241×
2.00Jul 1, 2024
20232×
1.30Jul 3, 20230.65Jun 30, 2023
20221×
0.60Jul 4, 2022
20211×
1.16Jul 7, 2021
20201×
0.20Jul 8, 2020
20191×
0.55Jul 3, 2019
20181×
1.40Jul 3, 2018
20171×
1.30Jul 4, 2017
20161×
1.00Jul 5, 2016
20151×
0.60Jul 6, 2015
20141×
0.30Jul 7, 2014
20131×
0.20Jul 8, 2013
20121×
0.20Jul 9, 2012
20111×
0.20Jul 12, 2011
20101×
0.25Sep 9, 2010
20091×
0.60Sep 23, 2009
20081×
0.59Sep 16, 2008
20061×
1.23Sep 5, 2006
20051×
0.89Aug 31, 2005

Stock Splits

  • Jun 16, 20221955:1949
  • Jun 25, 2009732:725